Recruiting

AI-Enabled Workflow

Sponsor:

Viz.ai, Inc.

Code:

NCT07118306

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Study ID

NCT07118306

Start date

Feb 27, 2026

Status verified date

Aug, 2026

Completion date

Dec, 2027

Anticipated

Primary completion date

Jul, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients aged 40 years or older at the time of arrival to the emergency department.
  • Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.
  • A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and/or antibiotics.
  • A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for >24 hours in emergency department/urgent care facility or resulting in death.
  • Patients on dual (LABA/LAMA, LABA/ICS, LAMA/ICS) or triple (LABA/LAMA/ICS) long-acting bronchodilator inhalers.

Exclusion Criteria:

  • Patients on bronchodilator inhaler monotherapy.
  • Patients leaving against medical advice or expiring during hospitalization.
  • Patients with tracheostomy.
  • Patients with advanced cancer.
  • Patients who have received a lung transplant.
  • Discharge to hospice care.
  • Transfer to another hospital.

Study Design

Enrollment

485 participants

Anticipated

Interventions and Outcome Measures

Arms

Experimental Cohort

Prospective patients presenting to sites after implementation of the digital health tool.

Control Cohort

Retrospective patients who presented to the same study sites under the standard of care clinical workflow before implementation of the digital health tool

Exploratory Cohort

Patients who had no prior respiratory specialist follow up before implementation of the digital health tool and are re-assessed for follow up after implementation of the digital health tool.

Primary outcome measure

  • To assess the effect of a digital health tool implementation on patient follow up with a respiratory specialist within 30 days after discharge for an acute COPD exacerbation resulting in an emergency department visit or hospitalization. [ Time Frame: From time of exacerbation to 30 days after discharge ]
  • To assess the effect of a digital health tool implementation on time to respiratory specialist follow-up after an acute COPD exacerbation resulting in an emergency department visit or hospitalization. [ Time Frame: Up to 1 year ]

Central Contacts and Locations

Locations

Advocate Lutheran General Hospital

Recruiting

Park Ridge, Illinois, United States, 60068

Contacts

Manager Clinical Trials Research, Multispecialty

920-360-9415alexander.albers@aah.org

Cooper University Health Care

Recruiting

Cherry Hill, New Jersey, United States, 08002

Contacts

Study Coordinator

856-342-2000Falcon-Tashi@cooperhealth.edu

Principal Investigator:

Ramya Lotano, MD

Thomas Jefferson University

Recruiting

Philadelphia, Pennsylvania, United States, 19107

Contacts

Research Coordinator

215-955-9181pritika.manna@jefferson.edu

Principal Investigator:

Ross Summer, MD

More Information

Sponsor

Viz.ai, Inc.

Last update posted

Sep 2, 2026

Last verified

Aug, 2026

Keywords

  • COPD
  • Chronic obstructive pulmonary disease
  • Exacerbation
  • VizCOPD

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Viz.ai, Inc. on 2026-09-02.